1. Home
  2. QNRX vs CISS Comparison

QNRX vs CISS Comparison

Compare QNRX & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • CISS
  • Stock Information
  • Founded
  • QNRX 2018
  • CISS 2022
  • Country
  • QNRX United States
  • CISS Greece
  • Employees
  • QNRX N/A
  • CISS N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • CISS Marine Transportation
  • Sector
  • QNRX Health Care
  • CISS Consumer Discretionary
  • Exchange
  • QNRX Nasdaq
  • CISS Nasdaq
  • Market Cap
  • QNRX 5.3M
  • CISS 5.3M
  • IPO Year
  • QNRX N/A
  • CISS N/A
  • Fundamental
  • Price
  • QNRX $0.57
  • CISS $1.23
  • Analyst Decision
  • QNRX Strong Buy
  • CISS
  • Analyst Count
  • QNRX 1
  • CISS 0
  • Target Price
  • QNRX $4.00
  • CISS N/A
  • AVG Volume (30 Days)
  • QNRX 1.4M
  • CISS 168.3K
  • Earning Date
  • QNRX 03-12-2025
  • CISS 11-18-2024
  • Dividend Yield
  • QNRX N/A
  • CISS N/A
  • EPS Growth
  • QNRX N/A
  • CISS N/A
  • EPS
  • QNRX N/A
  • CISS N/A
  • Revenue
  • QNRX N/A
  • CISS $46,661,732.00
  • Revenue This Year
  • QNRX N/A
  • CISS N/A
  • Revenue Next Year
  • QNRX N/A
  • CISS N/A
  • P/E Ratio
  • QNRX N/A
  • CISS N/A
  • Revenue Growth
  • QNRX N/A
  • CISS 491.48
  • 52 Week Low
  • QNRX $0.43
  • CISS $1.17
  • 52 Week High
  • QNRX $6.18
  • CISS $49.25
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 43.80
  • CISS 33.66
  • Support Level
  • QNRX $0.56
  • CISS $1.24
  • Resistance Level
  • QNRX $0.63
  • CISS $1.36
  • Average True Range (ATR)
  • QNRX 0.07
  • CISS 0.14
  • MACD
  • QNRX -0.00
  • CISS 0.01
  • Stochastic Oscillator
  • QNRX 11.56
  • CISS 8.00

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

Share on Social Networks: